12 Myalgic Encephalomyelitis Clinical Trials in New Brunswick, NJ (2026)

Q: How do I join a clinical trial in New Brunswick?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you.

Recruiting Myalgic Encephalomyelitis Studies in New Brunswick

NCT05581004Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

This is a first-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of enzelkitug when administered as a single agent and in combination with atezolizum...

New Brunswick, NJPHASE1450 participantsGenentech, Inc.

View Study Details

NCT05156983Recruiting

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagu...

New Brunswick, NJPHASE3440 participantsTakeda

View Study Details

NCT06033599Recruiting

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake...

New Brunswick, NJPHASE3420 participantsRutgers, The State University of New Jersey

View Study Details

NCT05245500Recruiting

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

This is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid tumor malignancy wit...

New Brunswick, NJPHASE1336 participantsBristol-Myers Squibb

View Study Details

NCT05915078Recruiting

Evaluation of Outcomes Following In-office Tympanostomy Using the Tula® System: a Prospective, Multi-center Registry

This prospective, single-arm, multicenter registry is being conducted to collect real world post-market data from patients aged from 6 months to 17 years of age who are undergoing an in-office ear tub...

New Brunswick, NJ200 participantsSmith & Nephew, Inc.

View Study Details

NCT03567889Recruiting

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of...

New Brunswick, NJPHASE3186 participantsPhilogen S.p.A.

View Study Details

NCT05419518Recruiting

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

The investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Add...

New Brunswick, NJPHASE2124 participantsRutgers, The State University of New Jersey

View Study Details

NCT07080242Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroen...

New Brunswick, NJPHASE1120 participantsSystImmune Inc.

View Study Details

NCT05308264Recruiting

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Phase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)...

New Brunswick, NJPHASE186 participantsRigel Pharmaceuticals

View Study Details

NCT06057935Recruiting

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

The purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal m...

New Brunswick, NJPHASE264 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05172245Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy ("chemo-radiation") in patients ...

New Brunswick, NJPHASE146 participantsNational Cancer Institute (NCI)

View Study Details

NCT07643012Recruiting

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

To evaluate the safety, tolerability, and preliminary efficacy of moderately hypofractionated (15-fraction) MR-guided adaptive pelvic IMRT in patients with endometrial cancer....

New Brunswick, NJNA30 participantsRutgers, The State University of New Jersey

View Study Details

About Myalgic Encephalomyelitis Clinical Trials in New Brunswick

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 12 myalgic encephalomyelitis clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 2,502 participants. Research is being sponsored by Genentech, Inc., Takeda, Rutgers, The State University of New Jersey and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in New Brunswick — FAQ

Are there myalgic encephalomyelitis clinical trials in New Brunswick?

Yes, there are 12 myalgic encephalomyelitis clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Brunswick?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.

Are clinical trials in New Brunswick free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 12 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 17, 2026 from ClinicalTrials.gov